Efficacy and Safety of Ambervin® and Standard Therapy in Hospitalized Patients With COVID-19
Clinical trial NCT05656495 · COMPLETED
Trial details
- NCT number
- NCT05656495
- Sponsor
- Promomed, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-28
- Primary completion
- 2022-11-22
- Enrollment
- 313
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.